<VariationArchive RecordType="classified" VariationID="529227" VariationName="NC_000009.12:g.(?_34646586)_(34651238_?)del" VariationType="Deletion" Accession="VCV000529227" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2018-05-28" MostRecentSubmission="2018-05-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="524448" VariationID="529227">
      <GeneList>
        <Gene Symbol="GALT" FullName="galactose-1-phosphate uridylyltransferase" GeneID="2592" HGNC_ID="HGNC:4135" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="34646675" stop="34651035" display_start="34646675" display_stop="34651035" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="34646585" stop="34650594" display_start="34646585" display_stop="34650594" Strand="+" />
          </Location>
          <OMIM>606999</OMIM>
        </Gene>
        <Gene Symbol="LOC130001683" FullName="ATAC-STARR-seq lymphoblastoid active region 28314" GeneID="130001683" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="34647100" stop="34647279" display_start="34647100" display_stop="34647279" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000009.12:g.(?_34646586)_(34651238_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" innerStart="34646586" innerStop="34651238" display_start="34646586" display_stop="34651238" variantLength="4653" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" innerStart="34646583" innerStop="34651235" display_start="34646583" display_stop="34651235" variantLength="4653" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.(?_34646586)_(34651238_?)del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.(?_34646586)_(34651238_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.(?_34646583)_(34651235_?)del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.(?_34646583)_(34651235_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000009.12:g.(?_34646586)_(34651238_?)del AND Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase" Accession="RCV000634560" Version="1">
        <ClassifiedConditionList TraitSetID="949">
          <ClassifiedCondition DB="MedGen" ID="C0268151">Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-11-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-11-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-28" MostRecentSubmission="2018-05-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11286505</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15841485</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17079880</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="949" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5173" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="230400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GALACTOSEMIA I</ElementValue>
                <XRef Type="MIM" ID="230400" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0016" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Transferase Deficiency Galactosemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase</ElementValue>
                <XRef ID="Deficiency+of+UTP-hexose-1-phosphate+uridylyltransferase/8206" DB="Genetic Alliance" />
                <XRef ID="124354006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactose-1-phosphate uridyltransferase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GALT deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactosemia, classic</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13639" />
                <XRef ID="13639" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The term "galactosemia" refers to disorders of galactose metabolism that include classic galactosemia, clinical variant galactosemia, and biochemical variant galactosemia (not covered in this chapter). This GeneReview focuses on: Classic galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage, bleeding, and E coli sepsis in untreated infants. If a lactose-restricted diet is provided during the first ten days of life, the neonatal signs usually quickly resolve and the complications of liver failure, sepsis, and neonatal death are prevented; however, despite adequate treatment from an early age, children with classic galactosemia remain at increased risk for developmental delays, speech problems (termed childhood apraxia of speech and dysarthria), and abnormalities of motor function. Almost all females with classic galactosemia manifest hypergonadatropic hypogonadism or premature ovarian insufficiency (POI). Clinical variant galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage including cirrhosis, and bleeding in untreated infants. This is exemplified by the disease that occurs in African Americans and native Africans in South Africa. Persons with clinical variant galactosemia may be missed with newborn screening as the hypergalactosemia is not as marked as in classic galactosemia and breath testing is normal. If a lactose-restricted diet is provided during the first ten days of life, the severe acute neonatal complications are usually prevented. African Americans with clinical variant galactosemia and adequate early treatment do not appear to be at risk for long-term complications, including POI.</Attribute>
                <XRef ID="NBK1518" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301691</ID>
                <ID Source="BookShelf">NBK1518</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25473725</ID>
                <ID Source="BookShelf">NBK258640</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Hypergalactosemia-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics Algorithm, Primary or Secondary Hypergalactosemia (Galactose Elevated)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Galactose-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated total galactose with normal GALT enzyme activity, Primary or Secondary Hypergalactosemia, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2021">
                <URL>https://www.acmg.net/PDFLibrary/Classical-Galactosemia-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Absent/Reduced Galactose-1-Phosphate Uridyltransferase (GALT), Classic Galactosemia, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2021">
                <URL>https://www.acmg.net/PDFLibrary/GALT-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Galactosemia (GALT Deficiency), 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Galactosemia-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Galactosemia (GALT Deficiency, Classical Galactosemia), 2012</CitationText>
              </Citation>
              <XRef ID="352" DB="Orphanet" />
              <XRef ID="79239" DB="Orphanet" />
              <XRef ID="C0268151" DB="MedGen" />
              <XRef ID="MONDO:0009258" DB="MONDO" />
              <XRef Type="MIM" ID="230400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1465345" SubmissionDate="2018-04-02" DateLastUpdated="2018-05-28" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="2871196|MedGen:C0268151" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000755889" DateUpdated="2018-05-28" DateCreated="2018-05-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17079880</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15841485</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11286505</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the GALT gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Similar deletions of the entire GALT sequence have been reported in the literature in individuals affected with galactosemia (PMID: 17079880, 15841485, 11286505). Loss-of-function variants in GALT are known to be pathogenic (PMID: 22944367). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.(?_34646583)_(34651235_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268151" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1465345" TraitType="Disease" MappingType="XRef" MappingValue="C0268151" MappingRef="MedGen">
        <MedGen CUI="C0268151" Name="Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

